Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1961 Feb 25;84(8):403–419.

Angiotensin, Aldosterone and Human Arterial Hypertension *

J Genest
PMCID: PMC1939287  PMID: 13704363

Full text

PDF
403

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOCK H. D., KRECKE H. J. Die Wirkung von synthetischem Hypertensin II auf die PAH- und Inulin-Clearánce, die renale Hamodynamik und die Diurese beim Menschen. Klin Wochenschr. 1958 Jan 15;36(2):69–74. doi: 10.1007/BF01486247. [DOI] [PubMed] [Google Scholar]
  2. BOCK K. D., KRECKE H. J., KUHN H. M. Untersuchungen über die Wirkung von synthetischem Hypertensin II auf Blutdruck, Atmung und Extremitätendurchblutung des Menschen. Klin Wochenschr. 1958 Mar 15;36(6):254–261. doi: 10.1007/BF01479198. [DOI] [PubMed] [Google Scholar]
  3. BUSH I. E. Methods of paper chromatography of steroids applicable to the study of steroids in mammalian blood and tissues. Biochem J. 1952 Jan;50(3):370–378. doi: 10.1042/bj0500370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. CONFERENCE on electrolyte and adrenal factors in human and experimental renal hypertension. Circulation. 1958 Apr;17(4 Pt 2):771–781. doi: 10.1161/01.cir.17.4.771. [DOI] [PubMed] [Google Scholar]
  5. DEANE H. W., MASSON G. M. C. Adrenal cortical changes in rats with various types of experimental hypertension. J Clin Endocrinol Metab. 1951 Feb;11(2):193–208. doi: 10.1210/jcem-11-2-193. [DOI] [PubMed] [Google Scholar]
  6. ELLIOTT D. F., PEART W. S. Amino-acid sequence in a hypertensin. Nature. 1956 Mar 17;177(4507):527–528. doi: 10.1038/177527a0. [DOI] [PubMed] [Google Scholar]
  7. ELMADJIAN F., HOPE J. M., LAMSON E. T. Excretion of epinephrine and norepinephrine in various emotional states. J Clin Endocrinol Metab. 1957 May;17(5):608–620. doi: 10.1210/jcem-17-5-608. [DOI] [PubMed] [Google Scholar]
  8. FRIEDMAN C. L., FRIEDMAN S. M., NAKASHIMA M. Extrarenal effects of intravenous pitressin in nephrectomized rats. Circ Res. 1956 Sep;4(5):557–564. doi: 10.1161/01.res.4.5.557. [DOI] [PubMed] [Google Scholar]
  9. FRIEDMAN S. M., FRIEDMAN C. L., NAKASHIMA M. Cationic shifts and blood pressure regulation. Circ Res. 1957 May;5(3):261–267. doi: 10.1161/01.res.5.3.261. [DOI] [PubMed] [Google Scholar]
  10. GARST J. B., SHUMWAY N. P., SCHWARTZ H., FARRELL G. L. Aldosterone excretion in essential hypertension. J Clin Endocrinol Metab. 1960 Oct;20:1351–1359. doi: 10.1210/jcem-20-10-1351. [DOI] [PubMed] [Google Scholar]
  11. GENEST J. Clinical states associated with abnormal aldosterone excretion. Can Med Assoc J. 1957 Oct 15;77(8):780–785. [PMC free article] [PubMed] [Google Scholar]
  12. GENEST J., JONES R. N., KOIW E., NOWACZYNSKI W. J., STEYERMARK P. R. Detailed study of a purified urinary aldosterone fraction. Can J Biochem Physiol. 1956 Sep;34(5):1023–1038. [PubMed] [Google Scholar]
  13. GENEST J., KOIW E., BEAUREGARD P., NOWACZYNSKI W., SANDOR T., BROUILLET J., BOLTE E., VERDY M., MARCAURELE J. Electrolyte and corticosteroid studies in a 15-year-old girl with primary aldosteronism and malignant hypertension. Metabolism. 1960 Jul;9:624–645. [PubMed] [Google Scholar]
  14. GENEST J., KOIW E., NOWACZYNSKI W., LEBOEUF G. Further studies on urinary aldosterone in human arterial hypertension. Proc Soc Exp Biol Med. 1958 Mar;97(3):676–679. doi: 10.3181/00379727-97-23843. [DOI] [PubMed] [Google Scholar]
  15. GENEST J., KOIW E., NOWACZYNSKI W., SANDOR T. Study of a large steroid spectrum in normal subjects and hypertensive patients. Acta Endocrinol (Copenh) 1960 Nov;35:413–425. doi: 10.1530/acta.0.xxxv0413. [DOI] [PubMed] [Google Scholar]
  16. GENEST J., LEMIEUX G., DAVIGNON A., KOIW E., NOWACZYNSKI W., STEYERMARK P. Human arterial hypertension: a state of mild chronic hyperaldosteronism? Science. 1956 Mar 23;123(3195):503–505. doi: 10.1126/science.123.3195.503. [DOI] [PubMed] [Google Scholar]
  17. HARTROFT P. M., HARTROFT W. S. Studies on renal juxtaglomerular cells. I. Variations produced by sodium chloride and desoxycorticosterone acetate. J Exp Med. 1953 Mar;97(3):415–429. doi: 10.1084/jem.97.3.415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. HILTON J. G. Adrenocorticotropic action of antidiuretic hormone. Circulation. 1960 May;21:1038–1046. doi: 10.1161/01.cir.21.5.1038. [DOI] [PubMed] [Google Scholar]
  19. KAGAWA C. M. Blocking urinary electrolyte effects of desoxycorticosterone with progesterone in rats. Proc Soc Exp Biol Med. 1958 Dec;99(3):705–707. doi: 10.3181/00379727-99-24471. [DOI] [PubMed] [Google Scholar]
  20. LANDAU R. L., LUGIBIHL K. Inhibition of the sodium-retaining influence of aldosterone by progesterone. J Clin Endocrinol Metab. 1958 Nov;18(11):1237–1245. doi: 10.1210/jcem-18-11-1237. [DOI] [PubMed] [Google Scholar]
  21. LARAGH J. H., ANGERS M., KELLY W. G., LIEBERMAN S. Hypotensive agents and pressor substances. The effect of epinephrine, norepinephrine, angiotensin II, and others on the secretory rate of aldosterone in man. JAMA. 1960 Sep 17;174:234–240. doi: 10.1001/jama.1960.03030030014003. [DOI] [PubMed] [Google Scholar]
  22. LARAGH J. H., ULICK S., JANUSZEWICZ V., DEMING Q. B., KELLY W. G., LIEBERMAN S. Aldosterone secretion and primary and malignant hypertension. J Clin Invest. 1960 Jul;39:1091–1106. doi: 10.1172/JCI104124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. NEHER R., WETTSTEIN A. Physicochemical detection and measurement of aldosterone in body fluids and tissues. Acta Endocrinol (Copenh) 1955 Apr;18(4):386–395. doi: 10.1530/acta.0.0180386. [DOI] [PubMed] [Google Scholar]
  24. NOWACZYNSKI W. J., KOIW E. A new paper chromatographic system for the separation of polar corticosteroids. J Lab Clin Med. 1957 May;49(5):815–818. [PubMed] [Google Scholar]
  25. NOWACZYNSKI W., GOLDNER M., GENEST J. Microdetermination of corticosteroids with tetrazolium derivatives. J Lab Clin Med. 1955 May;45(5):818–821. [PubMed] [Google Scholar]
  26. NOWACZYNSKI W., KOIW E., GENEST J. Chemical method for the determination of urinary aldosterone. Can J Biochem Physiol. 1957 Jun;35(6):425–443. [PubMed] [Google Scholar]
  27. NOWACZYNSKI W., KOIW E., GENEST J. Method for determination of urinary 5 beta, -pregnane-3 alpha, 17 alpha, 20 alpha -triol and delta 5-pregnene-3 beta, 17 alpha, 20 alpha -triol. J Clin Endocrinol Metab. 1960 Nov;20:1503–1514. doi: 10.1210/jcem-20-11-1503. [DOI] [PubMed] [Google Scholar]
  28. PAINE R., SMITH J. R., BUTCHER H. R., HOWARD F. A. Heart failure and pulmonary edema produced by certain neurologic stimuli. Circulation. 1952 May;5(5):759–765. doi: 10.1161/01.cir.5.5.759. [DOI] [PubMed] [Google Scholar]
  29. PALADINI A. C., BRAUN-MENENDEZ E., DEL FRADE I. S., MASSANI Z. M. The estimation of angiotensin in blood. J Lab Clin Med. 1959 Feb;53(2):264–271. [PubMed] [Google Scholar]
  30. PEART W. S. Hypertension and the kidney. II. Experimental basis of renal hypertension. Br Med J. 1959 Dec 26;2(5164):1421–1429. doi: 10.1136/bmj.2.5164.1421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. PITCOCK J. A., HARTROFT P. M., NEWMARK L. N. Increased renal pressor activity (renin) in sodium deficient rats and correlation with juxtaglomerular cell granulation. Proc Soc Exp Biol Med. 1959 Apr;100(4):868–869. doi: 10.3181/00379727-100-24807. [DOI] [PubMed] [Google Scholar]
  32. PITCOCK J. A., HARTROFT P. M. The juxtaglomerular cells in man and their relationship to the level of plasma sodium and to the zona glomerulosa of the adrenal cortex. Am J Pathol. 1958 Sep-Oct;34(5):863–883. [PMC free article] [PubMed] [Google Scholar]
  33. TAIT J. F., SIMPSON S. A., GRUNDY H. M. The effect of adrenal extract on mineral metabolism. Lancet. 1952 Jan 19;1(6699):122–124. doi: 10.1016/s0140-6736(52)92427-6. [DOI] [PubMed] [Google Scholar]
  34. TOBIAN L., FOX A. The effect of norepinephrine on the electrolyte composition of arterial smooth muscle. J Clin Invest. 1956 Mar;35(3):297–301. doi: 10.1172/JCI103277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. TOBIAN L. Interrelationship of electrolytes, juxtaglomerular cells and hypertension. Physiol Rev. 1960 Apr;40:280–312. doi: 10.1152/physrev.1960.40.2.280. [DOI] [PubMed] [Google Scholar]
  36. TOBIAN L. Physiology of the juxtaglomerular cells. Ann Intern Med. 1960 Feb;52:395–410. doi: 10.7326/0003-4819-52-2-395. [DOI] [PubMed] [Google Scholar]
  37. TOBIAN L., REDLEAF P. D. Ionic composition of the aorta in renal and adrenal hypertension. Am J Physiol. 1958 Feb;192(2):325–330. doi: 10.1152/ajplegacy.1958.192.2.325. [DOI] [PubMed] [Google Scholar]
  38. TOBIAN L. The electrolytes of arterial wall in experimental renal hypertension. Circ Res. 1956 Nov;4(6):671–675. doi: 10.1161/01.res.4.6.671. [DOI] [PubMed] [Google Scholar]
  39. TRONCHETTI F., MUCIO G., ROMANELLI R. Aldostérone et maladie vasculaire hypertensive. Ann Endocrinol (Paris) 1957 Jul-Aug;18(4):654–657. [PubMed] [Google Scholar]
  40. VENNING E. H., DYRENFURTH I. Aldosterone excretion in pregnancy. J Clin Endocrinol Metab. 1956 Mar;16(3):426–428. doi: 10.1210/jcem-16-3-426. [DOI] [PubMed] [Google Scholar]
  41. ZAFFARONI A., BURTON R. B. Identification of corticosteroids of beef adrenal extract by paper chromatography. J Biol Chem. 1951 Dec;193(2):749–767. [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES